When cytosolic PEPCK is used, the oxaloacetate will be converted to malate in the mitochondria, consuming NADH, and it is the malate that is brought of the mitochondria to the cytoplasm. There, malate is converted back to oxaloacetate, producing NADH in the cytoplasm, and then cytosolic PEPCK can act on the cytoplasmic oxaloacetate to form PEP.